- Home
- NUS vs CION Comparison
NUS vs CION Comparison
Compare NUS & CION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUS
- CION
- Stock Information
- Founded
- NUS 1984
- CION 2011
- Country
- NUS United States
- CION United States
- Employees
- NUS N/A
- CION N/A
- Industry
- NUS Other Pharmaceuticals
- CION Finance/Investors Services
- Sector
- NUS Health Care
- CION Finance
- Exchange
- NUS Nasdaq
- CION Nasdaq
- Market Cap
- NUS 440.8M
- CION 521.7M
- IPO Year
- NUS 1996
- CION N/A
- Fundamental
- Price
- NUS $8.20
- CION $9.62
- Analyst Decision
- NUS Hold
- CION Sell
- Analyst Count
- NUS 2
- CION 2
- Target Price
- NUS $6.88
- CION $11.00
- AVG Volume (30 Days)
- NUS 447.2K
- CION 239.3K
- Earning Date
- NUS 08-07-2025
- CION 08-07-2025
- Dividend Yield
- NUS 2.86%
- CION 14.91%
- EPS Growth
- NUS N/A
- CION N/A
- EPS
- NUS N/A
- CION N/A
- Revenue
- NUS $1,679,268,000.00
- CION $234,952,000.00
- Revenue This Year
- NUS N/A
- CION N/A
- Revenue Next Year
- NUS N/A
- CION N/A
- P/E Ratio
- NUS N/A
- CION N/A
- Revenue Growth
- NUS N/A
- CION N/A
- 52 Week Low
- NUS $5.32
- CION $8.51
- 52 Week High
- NUS $11.41
- CION $12.71
- Technical
- Relative Strength Index (RSI)
- NUS 44.45
- CION 40.87
- Support Level
- NUS $8.63
- CION $10.01
- Resistance Level
- NUS $8.97
- CION $10.27
- Average True Range (ATR)
- NUS 0.38
- CION 0.18
- MACD
- NUS -0.11
- CION -0.06
- Stochastic Oscillator
- NUS 8.19
- CION 22.16
About NUS Nu Skin Enterprises Inc.
Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.
About CION CION Investment Corporation
CION Invt Corp is an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company. The Company's portfolio is comprised of investments in senior secured debt, including first lien loans, second lien loans, and unitranche loans, and, to a lesser extent, collateralized securities, structured products and other similar securities, unsecured debt, and equity, of private and thinly-traded U.S. middle-market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation for investors.